No, the government cannot seize, break or 'bypass' pharmaceutical patents — even for COVID-19

Retrieved on: 2020-11-25 12:56:15

Tags for this article:

Intellectual property law

Patent law

Pharmaceutical industry

Invention

Click the tags to see associated articles and topics

No, the government cannot seize, break or 'bypass' pharmaceutical patents — even for COVID-19. View article details on hiswai:

Excerpt

Arguments for how Bayh-Dole applies to <b>remdesivir</b> are unconvincing, especially when the U.S. Army as funding agency appears to be disclaiming ...

Article found on: thehill.com

View Original Article